---
id: "action-establish-ai-governance"
type: "action-item"
source_timestamps: ["§ 3. Use strategic partnerships to unlock the value of AI in drug discovery and development.", "¶15"]
tags: ["governance", "risk-management", "partnerships"]
related: ["question-ai-ip-governance", "entity-msk", "entity-aws-ddw", "entity-triomics"]
action: "Create strict governance frameworks addressing data privacy and IP before forming external AI partnerships."
outcome: "Safe integration of frontier AI tools without compromising institutional data or intellectual property."
speakers: ["Anaeze C. Offodile II", "Kushal T. Kadakia", "Yashodhara Dash", "Whitney Snider", "Joseph C. Wu", "Selwyn M. Vickers"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# Establish AI Partnership Governance Frameworks

**Action:** Before engaging in strategic partnerships with external AI companies, AMCs must establish **thoughtful governance frameworks** to mitigate risks from **long-term dependence, data privacy, and intellectual-property leakage**. These should be informed by bodies like the **AMA (American Medical Association)**.

**Mechanism / examples:** [[entity-msk]] (10+ AI partnerships), [[entity-aws-ddw]], and [[entity-triomics]] under Pillar 3 of [[framework-amc-innovation-acceleration]]. The unresolved specifics are captured in [[question-ai-ip-governance]].

**Outcome:** safe integration of frontier AI tools without compromising institutional data or intellectual property.


## Related across articles
- [[action-establish-accountability-frameworks]]
- [[concept-hub-and-spoke-ai]]
- [[question-ai-ip-governance]]